News & Perspective

Sep 20, 2016

Sep 20, 2016

News Scan for Sep 20, 2016

MERS in Austria
Global flu update
Triclosan-containing sutures
Ebola strain comparison

Mar 21, 2016

Mar 21, 2016

News Scan for Mar 21, 2016

More Ebola in Guinea
Flu virus in coughs, breaths
H7N9 case in Hong Kong
New anthrax drug approved

Feb 12, 2016

Feb 12, 2016

News Scan for Feb 12, 2016

US flu ramps up
Two Saudi MERS cases
Yellow fever in Angola
DRC monkeypox outbreak
Global vaccine-derived polio
Harmless E coli in cheese

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 29, 2007

Oct 29, 2007

THE PANDEMIC VACCINE PUZZLE Part 3: H5N1 poses major immunologic challenges

Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»